Financhill
Sell
14

AMIX Quote, Financials, Valuation and Earnings

Last price:
$3.50
Seasonality move :
--
Day range:
$3.38 - $3.57
52-week range:
$2.88 - $152.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.33x
Volume:
59.5K
Avg. volume:
159.6K
1-year change:
--
Market cap:
$4M
Revenue:
--
EPS (TTM):
-$13.96
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $745K $2.2M
Selling, General & Admin -- -- -- $1.2M $5.2M
Other Inc / (Exp) -- -- -- -- -$8M
Operating Expenses -- -- -- $2M $7.5M
Operating Income -- -- -- -$2M -$7.5M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$2M -$15.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -$2M -$15.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$2M -$15.4M
 
Basic EPS (Cont. Ops) -- -- -- -$1.88 -$21.00
Diluted EPS (Cont. Ops) -- -- -- -$1.88 -$21.00
Weighted Average Basic Share -- -- -- $1.1M $731.3K
Weighted Average Diluted Share -- -- -- $1.1M $731.3K
 
EBITDA -- -- -- -$2M -$15.3M
EBIT -- -- -- -$2M -$15.3M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -$2M -$7.5M
Operating Income (Adjusted) -- -- -- -$2M -$15.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $471K $1.2M
Selling, General & Admin -- -- -- $793K $1.7M
Other Inc / (Exp) -- -- -- -$4.8M --
Operating Expenses -- -- -- $1.3M $2.8M
Operating Income -- -- -- -$1.3M -$2.8M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$6M -$2.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -$6M -$2.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$6M -$2.8M
 
Basic EPS (Cont. Ops) -- -- -- -$5.72 -$2.47
Diluted EPS (Cont. Ops) -- -- -- -$5.72 -$2.47
Weighted Average Basic Share -- -- -- $1.1M $1.1M
Weighted Average Diluted Share -- -- -- $1.1M $1.1M
 
EBITDA -- -- -- -$6M -$2.7M
EBIT -- -- -- -$6M -$2.8M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -$1.3M -$2.8M
Operating Income (Adjusted) -- -- -- -$6M -$2.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $1.4M $3.6M
Selling, General & Admin -- -- -- $1.9M $7.4M
Other Inc / (Exp) -- -- -- -$4.8M -$3.2M
Operating Expenses -- -- -- $3.3M $10.9M
Operating Income -- -- -- -$3.3M -$10.9M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$8.1M -$14M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- -$14M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$8.1M -$14M
 
Basic EPS (Cont. Ops) -- -- -- -$7.68 -$13.96
Diluted EPS (Cont. Ops) -- -- -- -$7.68 -$13.96
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -$8.1M -$13.7M
EBIT -- -- -- -$8.1M -$13.9M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -$3.3M -$10.9M
Operating Income (Adjusted) -- -- -- -$8.1M -$13.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $839K $2.1M
Selling, General & Admin -- -- -- $1.3M $3.5M
Other Inc / (Exp) -- -- -- -$4.8M --
Operating Expenses -- -- -- $2.1M $5.6M
Operating Income -- -- -- -$2.1M -$5.6M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$6.9M -$5.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -$6.9M -$5.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$6.9M -$5.5M
 
Basic EPS (Cont. Ops) -- -- -- -$6.54 -$5.27
Diluted EPS (Cont. Ops) -- -- -- -$6.54 -$5.27
Weighted Average Basic Share -- -- -- $2.1M $2.1M
Weighted Average Diluted Share -- -- -- $2.1M $2.1M
 
EBITDA -- -- -- -$6.9M -$5.3M
EBIT -- -- -- -$6.9M -$5.4M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -$2.1M -$5.6M
Operating Income (Adjusted) -- -- -- -$6.9M -$5.4M
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Cash and Equivalents -- -- -- $865K $8.6M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- $783K
Total Current Assets -- -- -- $865K $9.4M
 
Property Plant And Equipment -- -- -- -- $16K
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- $865K $9.4M
 
Accounts Payable -- -- -- $173K $492K
Accrued Expenses -- -- -- $48K $285K
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- -- $221K $777K
 
Long-Term Debt -- -- -- -- $1M
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- $221K $1.8M
 
Common Stock -- -- -- $12K $19K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- $644K $7.6M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- $644K $7.6M
 
Total Liabilities and Equity -- -- -- $865K $9.4M
Cash and Short Terms -- -- -- $865K $8.6M
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- -- -- -- $5.2M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- $199K
Total Current Assets -- -- -- -- $5.4M
 
Property Plant And Equipment -- -- -- -- $17K
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- -- $5.4M
 
Accounts Payable -- -- -- -- $574K
Accrued Expenses -- -- -- -- $683K
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- -- -- $1.3M
 
Long-Term Debt -- -- -- -- $1.1M
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- -- $2.3M
 
Common Stock -- -- -- -- $1K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- -- $3M
 
Total Liabilities and Equity -- -- -- -- $5.4M
Cash and Short Terms -- -- -- -- $5.2M
Total Debt -- -- -- -- --
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders -- -- -- -$2M -$15.4M
Depreciation & Amoritzation -- -- -- -- $81K
Stock-Based Compensation -- -- -- -- $618K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$1.9M -$6.6M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- -$19K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- $2M
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- -$1.3M
Cash From Financing -- -- -- $675K $14.4M
 
Beginning Cash (CF) -- -- -- $2M $865K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$1.2M $7.7M
Ending Cash (CF) -- -- -- $865K $8.6M
 
Levered Free Cash Flow -- -- -- -$1.9M -$6.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -$6M -$2.8M
Depreciation & Amoritzation -- -- -- -- $45K
Stock-Based Compensation -- -- -- $151K $445K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$1.1M -$1.6M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $350K --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- $350K --
 
Beginning Cash (CF) -- -- -- $2.9M $6.8M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$794K -$1.6M
Ending Cash (CF) -- -- -- $2.1M $5.2M
 
Levered Free Cash Flow -- -- -- -$1.1M -$1.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- -$14M
Depreciation & Amoritzation -- -- -- -- $169K
Stock-Based Compensation -- -- -- $151K $1.3M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- -$8.3M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- -$24K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- $11.3M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- $3M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- -$8.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -$6.9M -$5.5M
Depreciation & Amoritzation -- -- -- -- $88K
Stock-Based Compensation -- -- -- $151K $805K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$1.8M -$3.4M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- -$5K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $350K --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$105K --
Cash From Financing -- -- -- $3.1M --
 
Beginning Cash (CF) -- -- -- $3.8M $15.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $1.3M -$3.5M
Ending Cash (CF) -- -- -- $5.1M $11.9M
 
Levered Free Cash Flow -- -- -- -$1.8M -$3.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Tesla Going to Buy Uber?
Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large,…

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Sell
40
MSTR alert for Dec 24

MicroStrategy [MSTR] is down 8.7% over the past day.

Sell
26
NUTX alert for Dec 24

Nutex Health [NUTX] is up 9.77% over the past day.

Sell
48
VRNA alert for Dec 24

Verona Pharma PLC [VRNA] is up 7.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock